SRI International's Research on Nicotine Use and Dependence Featured in the National Cancer Institute's Tobacco Control Monogr... ( MENLO PARK Calif. Sept. 1...)

HOME >> MEDICINE >> NEWS

SRI International's Research on Nicotine Use and Dependence Featured in the National Cancer Institute's Tobacco Control Monograph Series

Date:9/10/2009

MENLO PARK, Calif., Sept. 10 /PRNewswire/ -- SRI International, an independent nonprofit research and development institute, today announced that new research on nicotine dependence is featured in National Cancer Institute's Tobacco Control Monograph 20, Phenotypes and Endophenotypes: Foundations for Genetic Studies of Nicotine Use and Dependence. Gary E. Swan, Ph.D., director of SRI's Center for Health Sciences, was the senior scientific editor of the monograph.

"It was an honor to work with a broad range of experts to develop a greater understanding of behavioral genetics and how these findings can improve public health approaches to tobacco control," said Dr. Swan. "By understanding the role of genetics in the context of nicotine dependence, more effective treatment and prevention programs can be developed."

New studies by researchers from SRI's Center for Health Sciences are described in the monograph, including an analysis of subgroups among adolescent tobacco users. This research shows that the subgroup that started smoking at a younger age and maintained a high level of tobacco use is at high risk for adult nicotine dependence. The monograph also presents the first example of a metabolism ontology--a formal system to represent causal relationships between the administration of nicotine and its subsequent metabolism through the action of various genes. The monograph further summarizes work from the first-ever twin study of nicotine metabolism, work that was published previously and conducted by scientists working at SRI and elsewhere in the United States and Canada.

In the monograph, a review of current studies of tobacco use in twins and families is presented. The review concludes that nicotine dependence is a complex trait with genetic and environmental underpinnings that requires a cross-disciplinary approach to research to improve understanding of this behavior a
'/>"/>

SOURCE SRI International
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. Research Seeks Cause of Preeclampsia
2. Sleep helps reduce errors in memory, MSU research suggests
3. UCSB researchers develop drug delivery system using nanoparticles and lasers
4. University of Arizona researchers seek safer cystic fibrosis test
5. Research Demonstrates that HerbalSciences Proprietary Elderberry Extract Prevents in Vitro H1N1 Influenza Infection
6. $0.00 Penny System to Jump Start Global Economy Developed by DNA and MIND Researcher.
7. Clarus Research Group Survey: Top Political Strategists React to Obamas Health Care Speech, Rate Effectiveness
8. New AOTMP Research Reveals that 21% of Enterprises Don't Have or Don't Know if they Have Telecom Expense Management Reporting
9. $3.5 million NIH grant supports AIDS vaccine research at UC Santa Cruz
10. DSS Research Announces Outbound Education and Verification Program Meets New CMS Requirements
11. Research Firm will Obtain Americans Reactions to the Presidents Speech on Health Care Reform

Post Your Comments:

(Date:12/16/2009)... Dec. 16 HealthSciences Institute will ... care professionals, teams and organizations who serve ... chronic diseases in employer, health plan, medical ... collaborative will offer free, noncommercial webinars on ... disease prevention, management and care improvement. Each ...

(Date:12/16/2009)... Trust Sanger Institute announce the first comprehensive analyses of ... mutations in the DNA of cancer cells which are ... malignant melanoma and a lung cancer, reveal for the ... of two cancers. , Lung cancer causes around one ... with smoking. The number of mutations found suggest that ...

(Date:12/16/2009)... Newborn-Safe Skin Care Products from Episencial Offers Planet-Friendly Organics, Solar-Powered ... , ... Los Angeles, CA (PRWEB) ... now have an authentic, affordable choice in all natural skin ... its eponymous product line for young children featuring the beloved ...

(Date:12/16/2009)... leader of Digital Pen and Paper technology and the provider ... today announced that it is ranked among the Fastest Growing ... 2009. , ... (PRWEB) December 16, ... for the capture, digitalization and management of handwritten data. Kayentis ...

(Date:12/16/2009)... 8 percent of children are uninsured, government report finds ... first six months of this year, 45.4 million Americans ... population -- had no health insurance, according to new ... addition, 58.4 million (19.4 percent) people of all ages ... year prior to the interview, and 31.9 million (10.6 ...

Breaking Medicine News(10 mins):Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 2 Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 3 Health News:Lung cancer and melanoma laid bare 2 Health News:Lung cancer and melanoma laid bare 3 Health News:Lung cancer and melanoma laid bare 4 Health News:Lung cancer and melanoma laid bare 5 Health News:Lung cancer and melanoma laid bare 6 Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 2 Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 3 Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 4 Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 5 Health News:With a Revenue Growth of Over 500% During the Last 5 Years, Kayentis is Ranked on the Deloitte Technology Fast 500 -- EMEA 2009 2 Health News:Over 45 Million Americans Now Lack Health Insurance 2

[1] New Learning Collaborative to Prepare Clinicians for Better Chronic Care [1] Lung cancer and melanoma laid bare [1] New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" [0] With a Revenue Growth of Over 500% During the Last 5 Years, Kayentis is Ranked on the Deloitte Technology Fast 500 -- EMEA 2009 [1] Over 45 Million Americans Now Lack Health Insurance

... The Cystic Fibrosis Foundation reported today that key indicators ... lung function and nutritional status -- are rising nationwide ... the outlook for people with CF continues to improve ... due to quality improvement programs spearheaded by the CF ...

... 28 The newest product offered by,Terumo ... Terumo Interventional Systems announces the launch ... the occlusion of blood,vessels, vascular malformations, and ... embolization system with a hydrogel coating that ...

... 28 The following letter is,being released by CEL-SCI ... Dear Fellow Shareholders:, Our Company underwent a wonderful ... development to a late-stage biotechnology,company. We are now one ... a,completely novel medicine with blockbuster potential ready to go ...

... is the latest American Chemical Society (ACS) News Service Weekly ... & Engineering News.,Please credit the individual journal or the American ... CONTENT IS FOR IMMEDIATE USE EXCEPT ARTICLE #5, which is ... , ARTICLE #1 FOR IMMEDIATE RELEASE ...

... Research Institute (CRI) announced today that it has brought ... Sabin Vaccine Institute, and the Cancer Vaccine Collaborative, a ... Ludwig Institute for Cancer Research (LICR), to form the ... a unified voice in the cancer vaccine field and ...

... 4:30 p.m. Eastern Time -, SAN FRANCISCO, Jan. ... that, based on its end-of-Phase 2 meeting,with the U.S. ... a pivotal confirmatory Phase 3 trial of Dimebon(TM) for,mild-to-moderate ... The FDA informed Medivation that the company,s previously completed,trial ...

Cystic Fibrosis Foundation reports upward trend for key health outcomes Terumo Launches the New AZUR(TM) Peripheral HydroCoil(R) Embolization System with Expanding Hydrogel Technology CEL-SCI Corporation Releases Letter to Shareholders American Chemical Society's weekly PressPac -- Jan. 23, 2008 Cancer Vaccine Consortium and Cancer Vaccine Collaborative unite under the Cancer Research Institute Medivation Plans to Initiate Pivotal Confirmatory Phase 3 Trial of Dimebon(TM) for Alzheimer's Disease in Second Quarter of 2008

(Date:12/16/2009)... 16 Siemens Healthcare today ... to help healthcare ... deadlines defined within the HITECH provision of ... Featuring zero-percent interest terms for ... defer up-front payments associated with their technology ...

(Date:12/16/2009)... -- BioSpecifics Technologies Corp. (Nasdaq: BSTC ), ... products, today announced top-line efficacy and safety results ... for the treatment of Peyronie,s disease. Peyronie,s disease ... on the shaft of the penis, which can ... or impossible in advanced cases. The Phase 2b ...

(Date:12/16/2009)... MAQUET Cardiovascular LLC, a leading ... it has signed a three-year single source ... supply contracting company, for MAQUET,s market-leading VASOVIEW ... products assist healthcare providers in obtaining veins ... only small incisions. This allows for faster ...

Breaking Medicine Technology:Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use 2 Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use 3 Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use 4 BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 2 BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 3 BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 4 MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 2 MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 3 MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 4 New Editor Named for International Journal Of Nursing Terminologies 26amp 3B Classifications 59323 1 New Editor Named for International Journal Of Nursing Terminologies 26amp 3B Classifications 59323 2 Aon Declares Quarterly Dividend 59320 1 Aon Declares Quarterly Dividend 59320 2 Hogs n Hens for Hope NCPC BBQ Cook Off 26amp 3B Festival October 17 at Duplin County Events Center Features Fun for the Whole Family and Benefits Laz 59317 1 Hogs n Hens for Hope NCPC BBQ Cook Off 26amp 3B Festival October 17 at Duplin County Events Center Features Fun for the Whole Family and Benefits Laz 59317 2

[0] Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use [0] BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease [0] MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices

... Assess Safety and Dose-Sparing Capability of Iomai Adjuvant ... ... Corporation,(Nasdaq: IOMI ) today announced that it has begun dosing in ... the,company,s immunostimulant patch when used in combination with an injected,H5N1 influenza vaccine. ...

... ANN ARBOR, Mich., Sept. 6 Terumo Heart ... Launch Symposium at the European,Association of Cardio-Thoracic Surgeons ... (Logo: http://www.newscom.com/cgi-bin/prnh/20061027/DEF004LOGO ... ) A summary of the European ...

Other Medicine Technology:Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine 2 Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine 3 Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine 4 Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September 2

Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

Medicine Products:

AFB Identification AFB Susceptibility Panel AFB Culture (Includes AFB Stain 0060151)Adrenocorticotropic Hormone Stimulation, 30 Minutes

SRI International's Research on Nicotine Use and Dependence Featured in the National Cancer Institute's Tobacco Control Monogr...( MENLO PARK Calif. Sept. 1...),Health